Charlie Schick, PhD’s Post

MassMEDIC is hosting their next Regulatory Roundup on 13nov. These roundups offer valuable insights and guidance for navigating the FDA as a medtech company. I strongly recommend those planning, or in the middle of, regulatory filings to attend. #fda #medtech #regulatory

On this Friday I’d like to share a motto of mine: Aut viam inveniam aut faciam. Either I will find a way or I will make one. Challenges, constraints, and barriers are not there to stop you but to teach you and push you to be better, to think differently, to clarify what needs to be done. There’s always a way forward. Always. Do you agree? What’s your motto? (image courtesy of Geoffrey (ChatGPT) when asked for a related image - caught your eye, didn’t it?)

FINBB (the Finnish Biobanks) have opened registration for their 30 September live and online symposium: "From Target Discovery to Precision Medicine – the Unique Potential of Finnish Biobanks in Biomedical Research" (see document below for agenda) To register or learn more: https://lnkd.in/emi2DWWQ

Finnish history and expertise in microelectronics, sensors, chips, embedded hardware and software has led to a rich ecosystem around medical devices and health wearables. Yes, ŌURA and Polar Electro Oy are not the only ones. This article presents five Finnish wearable startups in patient monitoring, cardiac arrhythmia, glucose monitoring, and mental health. #wearables #health #finland #medtech #devices #sensors

On this Friday, I offer you this: check out Archetype AI and their platform for 'physical AI'. I've been thinking a lot of the fusion of physical and AI, so I wrote up some comments on these guys and what I feel is missing from their message. Let me know what you think.

On this Friday, I leave you with this: some musings of mine on genAI memory. What do you think? Has genAI become too rememberfull for you? https://lnkd.in/eidz7xaq

This is the kind of funding Business Finland provides early stage companies in Finland who are challenged by high technological and market-entry risks. Multiple funding phases of €400k each, two which are grants, contributing up to 75% of the company's R&D budget. This kind of funding is one reason foreign companies set up R&D in Finland. Of course, the other reasons are the business environment, the talented and innovative ecosystem, and the social environment (rated happiest country, 7 times in a row). Message me if you want to know more. #funding #research #finland

Bayer has been leading this great program to address problems in running clinical trials. They chose to run the program in Finland, to tap into Finland's unique combination of enabling legislation, excellent ecosystem, and national mindset. Read more about it in the link below. #clinicaltrials #innovation

On this Friday, I leave you with some important advice: stretch your mind. If you surround yourself with the same-old, read the same-old, do the same-old - you will just think and make the same-old. Therefore, to stretch you mind, I offer a newsletter on manufacturing that always delights me, bringing up things I normally would not encounter - knife sharpening, refrigerators, construction sites, materials, infrastructure, and, of course, so many aspects of manufacturing. Here's a recent edition. Expand you mind and enjoy. #manufacturing #thinking #newsletter

Our latest healthcare program is officially underway, to drive the adoption of innovative digital solutions to enhance the healthcare sector (better target for investments and collaborations) and drive exports (growth for companies as they go global). Running until 2028, the program is set to support research and development initiatives with a substantial €80 million fund. #health #digitalhealth #innovation #finland #personlizedmedicine